Recurrent Plasmodium falciparum Malaria after Delayed Hemolysis Induced by Artemether-Lumefantrine.

Am J Trop Med HygSep 17, 2026 (epub)
Case ReportInfectious DiseasesHematologyOpen access

Kosuke Asano, Tokio Hoshina, Tomomi Miyamoto et al.

✦ AI-curated · Sources linked

Case in brief

A previously healthy 39-year-old Japanese man developed Plasmodium falciparum malaria after travel to Togo and received artemether-lumefantrine in the Philippines. Persistent fever and fatigue led to hospital assessment, where delayed hemolysis attributed to treatment was diagnosed. He improved with supportive care, including transfusion, but was later readmitted with malaria recrudescence and hemolytic anemia. Atovaquone-proguanil treatment was followed by clinical improvement.

What made this case unusual

Delayed hemolysis after artemether-lumefantrine was followed by recrudescent P. falciparum malaria with hemolytic anemia, linking two post-treatment complications in one patient.

Diagnostic / clinical pearl

Persistent or recurrent symptoms after artemether-lumefantrine warrant assessment for both delayed hemolysis and recrudescent malaria.

Why it matters

The authors suggest considering careful follow-up for at least 4 weeks after artemether-lumefantrine treatment.

Source

Published in Am J Trop Med Hyg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.